PubRank

Martin Puhr

Author PubWeight™ 10.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. Endocr Relat Cancer 2010 1.16
2 PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21. Am J Pathol 2012 1.02
3 Interleukin-6: a multifunctional targetable cytokine in human prostate cancer. Mol Cell Endocrinol 2011 1.00
4 Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases. Am J Pathol 2009 0.94
5 Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer. Am J Pathol 2006 0.90
6 SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer. Endocr Relat Cancer 2014 0.89
7 In vitro model systems to study androgen receptor signaling in prostate cancer. Endocr Relat Cancer 2013 0.89
8 Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cells. Prostate 2008 0.89
9 Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion. Endocr Relat Cancer 2007 0.89
10 SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner. Lab Invest 2012 0.77
11 Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivo. Int J Mol Sci 2013 0.75